Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA / ACCESS Newswire / December 5, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the “Company”), ...
The complainant, Mr. Raman, took admission in the D-Pharmacy (two-year course) at the Institute of Engineering & Technology ...
As Big Pharma braces for a massive revenue crash when patents on blockbuster drugs expire, an unexpected player is stepping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback